Cargando…

Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration

BACKGROUND: Mitomycin C (MMC) is an antitumor agent that is often administered intravesically to treat bladder cancer. Pharmacologically optimized studies have suggested varying methods to optimize delivery, with drug concentration and solution volume being the main drivers. However, these MMC conce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Myers, Alan L., Zhang, Yan-Ping, Kawedia, Jitesh D., Zhou, Ximin, Sobocinski, Stacey M., Metcalfe, Michael J., Kramer, Mark A., Dinney, Colin P. N., Kamat, Ashish M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427054/ https://www.ncbi.nlm.nih.gov/pubmed/28470465 http://dx.doi.org/10.1007/s40268-017-0183-y

Ejemplares similares

Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate
por: Kokorovic, Andrea, et al.
Publicado: (2021)

Intravesical Instillation of Mitomycin C: A Cause of Delayed Bladder Perforation?
por: Penna, Marta, et al.
Publicado: (2012)

A rare complication of intravesical early instillation of mitomycin C after TURBT
por: Hatem, Humam, et al.
Publicado: (2019)

Chitosan/β-glycerophosphate in situ gelling mucoadhesive systems for intravesical delivery of mitomycin-C
por: Kolawole, Oluwadamilola M., et al.
Publicado: (2019)

Comparison of intravesical bacillus Calmette-Guerin and mitomycin C administration for non-muscle invasive bladder cancer: A meta-analysis and systematic review
por: JIANG, SHANG-JUN, et al.
Publicado: (2016)

Redefining the role of immediate intravesical instillation of mitomycin C in non-muscle invasive bladder cancer
por: Batura, Deepak
Publicado: (2018)

Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model
por: Tamura, Koetsu, et al.
Publicado: (2015)

Comparative study of sequential intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma- a randomized trial
por: Jayant, Kumar, et al.
Publicado: (2015)

Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo(®) working party
por: Alfred Witjes, J., et al.
Publicado: (2009)

Increased Anticancer Efficacy of Intravesical Mitomycin C Therapy when Combined with a PCNA Targeting Peptide()
por: Gederaas, Odrun A., et al.
Publicado: (2014)

Editorial on the value of an immediate intravesical instillation of mitomycin C in patients with non-muscle-invasive bladder cancer
por: Oosterlinck, Willem, et al.
Publicado: (2018)

Calcification of bladder wall after intravesical mitomycin C therapy: a case report and review of literature
por: Chang, Dwayne T. S., et al.
Publicado: (2020)

Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
por: Li, Roger, et al.
Publicado: (2017)

Solubilization of Hydrophobic Dyes in Surfactant Solutions
por: Tehrani-Bagha, Ali Reza, et al.
Publicado: (2013)

Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients
por: Conroy, Samantha, et al.
Publicado: (2022)

Comparing adverse effects, short term outcomes, and cost implications of hyperthermic intravesical chemotherapy with Mitomycin-C and intravesical bacillus Calmette–Guerin instillation (Moscow-I strain) in the management of intermediate and high-risk nonmuscle invasive bladder cancer
por: Thyavihally, Yuvaraja B., et al.
Publicado: (2021)

An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers
por: Oosterlinck, Willem, et al.
Publicado: (2018)

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review
por: Schmidt, Stefanie, et al.
Publicado: (2020)

Novel in-situ gel for intravesical administration of ketorolac
por: Sherif, Abdelrahman Y., et al.
Publicado: (2018)

The Preparation of Electrolyte Hydrogels with the Water Solubilization of Polybenzoxazine
por: Ohsedo, Yutaka, et al.
Publicado: (2023)

Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study
por: Oshiro, Hisashi, et al.
Publicado: (2016)

Two routes of administration of mitomycin C in a trabeculectomy
por: Pillai, Manju, et al.
Publicado: (2023)

Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non‐muscle‐invasive bladder cancer: a randomised clinical trial
por: Miyata, Yasuyoshi, et al.
Publicado: (2021)

Intravesical mitomycin C efficacy in acidic and alkaline urinary pH: impact on recurrence-free survival rate after TURBT
por: Naeem, Muhammad Tayyab, et al.
Publicado: (2023)

Preparation and Cyclodextrin Solubilization of the Antibacterial Agent Benzoyl Metronidazole
por: Huang, Qing, et al.
Publicado: (2013)

Preparation and Characterization of Amorphous Solid Dispersions for the Solubilization of Fenretinide
por: Zuccari, Guendalina, et al.
Publicado: (2023)

Comparison of sterile water irrigation versus intravesical mitomycin C in preventing recurrence of nonmuscle invasive bladder cancer after transurethral resection
por: Bijalwan, Priyank, et al.
Publicado: (2017)

Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial
por: Li, Rongxin, et al.
Publicado: (2020)

Methods for direct determination of mitomycin C in aqueous solutions and in urine
por: Marín, Dolores, et al.
Publicado: (1998)

Solubilization and thermodynamic properties of simvastatin in various micellar solutions of different non-ionic surfactants: Computational modeling and solubilization capacity
por: Shakeel, Faiyaz, et al.
Publicado: (2021)

Genetic Variations in the Transforming Growth Factor Beta Pathway as Predictors of Bladder Cancer Risk
por: Wei, Hua, et al.
Publicado: (2012)

Towards Rational Biosurfactant Design—Predicting Solubilization in Rhamnolipid Solutions
por: Kłosowska-Chomiczewska, Ilona E., et al.
Publicado: (2021)

A Pilot Study on Intravesical Administration of Curcumin for Cystitis Glandularis
por: Lu, Qiong, et al.
Publicado: (2013)

Bladder Uptake of Liposomes after Intravesical Administration Occurs by Endocytosis
por: Rajaganapathy, Bharathi Raja, et al.
Publicado: (2015)

Use of monitoring levels of soluble forms of cytokeratin 18 in the urine of patients with superficial bladder cancer following intravesical Ad-IFNα/Syn3 treatment in a Phase l study
por: Benedict, William F., et al.
Publicado: (2014)

Nonionic Microemulsions as Solubilizers of Hydrophobic Drugs: Solubilization of Paclitaxel
por: Lo, Jen-Ting, et al.
Publicado: (2016)

Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study
por: Murakami, Kaoru, et al.
Publicado: (2022)

Acute Pericarditis Occurring Three Days after Intravesical Instillation of Mitomycin C after Transurethral Bladder Tumor Resection in a 64-Year-Old Woman
por: Meghrajani, Vineet, et al.
Publicado: (2018)

Intravesical Tension-Free Vaginal Tape Removal: Is There a Single Solution?
por: Zakri, Rhana H., et al.
Publicado: (2011)

Inclusion Complex of Isoliquiritigenin With Sulfobutyl Ether-β-Cyclodextrin: Preparation, Characterization, Inclusion Mode, Solubilization, and Stability
por: Wu, Xiaozheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1o328381agpci73m40ues2l1uf